Inhibition of the PD-1 immune checkpoint and the development of heart failure in the presence of prior cardiac ischemia
{{output}}
Aims: Immune checkpoint inhibitors (ICI) have revolutionized cancer treatment. However, their use often leads to cardiovascular adverse effects, including cardiac dysfunction. Here, we hypothesized that a prior cardiac ischemic i... ...
